09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
›9:00 (30min)
Proteomic advancements in neurodegenerative disorders
Peter Nilsson, KTH Royal Institute of Technology and SciLifeLab, Stockholm, Sweden
Neuroproteomics within the Human Protein Atlas
Peter Nilsson, KTH Royal Institute of Technology and SciLifeLab, Stockholm, Sweden
Neuroproteomics within the Human Protein Atlas
› Glending III
9:00 - 9:30 (30min)
Proteomic advancements in neurodegenerative disorders
Glending III
Peter Nilsson, KTH Royal Institute of Technology and SciLifeLab, Stockholm, Sweden
Neuroproteomics within the Human Protein Atlas
›9:30 (30min)
Proteomic advancements in neurodegenerative disorders
Sofia Bergström, KTH Royal Institute of Technology and SciLifeLab, Stockholm, Sweden
Protein signatures across neurodegenerative diseases
Sofia Bergström, KTH Royal Institute of Technology and SciLifeLab, Stockholm, Sweden
Protein signatures across neurodegenerative diseases
› Glending III
9:30 - 10:00 (30min)
Proteomic advancements in neurodegenerative disorders
Glending III
Sofia Bergström, KTH Royal Institute of Technology and SciLifeLab, Stockholm, Sweden
Protein signatures across neurodegenerative diseases
›10:00 (30min)
Proteomic advancements in neurodegenerative disorders
Katrin Marcus, Ruhr-Universität Bochum, Germany
Our last 20 years with neuromelanin
Katrin Marcus, Ruhr-Universität Bochum, Germany
Our last 20 years with neuromelanin
› Glending III
10:00 - 10:30 (30min)
Proteomic advancements in neurodegenerative disorders
Glending III
Katrin Marcus, Ruhr-Universität Bochum, Germany
Our last 20 years with neuromelanin
›10:30 (30min)
Proteomic advancements in neurodegenerative disorders
Maximilian Wulf, Ruhr-Universität Bochum, Germany
Neuromelanin granules as a use case for spatial proteomics
Maximilian Wulf, Ruhr-Universität Bochum, Germany
Neuromelanin granules as a use case for spatial proteomics
› Glending III
10:30 - 11:00 (30min)
Proteomic advancements in neurodegenerative disorders
Glending III
Maximilian Wulf, Ruhr-Universität Bochum, Germany
Neuromelanin granules as a use case for spatial proteomics
11:00 - 11:30 (30min)
Coffee break
Glending II
›11:30 (30min)
Proteomic advancements in neurodegenerative disorders
Darragh O'Brien, University of Oxford, UK
Tau filaments are tethered within brain extracellular vesicles in Alzheimer's disease
Darragh O'Brien, University of Oxford, UK
Tau filaments are tethered within brain extracellular vesicles in Alzheimer's disease
› Glending III
11:30 - 12:00 (30min)
Proteomic advancements in neurodegenerative disorders
Glending III
Darragh O'Brien, University of Oxford, UK
Tau filaments are tethered within brain extracellular vesicles in Alzheimer's disease
›12:00 (15min)
Proteomic advancements in neurodegenerative disorders
Dhruti Doddaballapur, Manchester University, UK
Parkinson's as a metabolism disorder
Dhruti Doddaballapur, Manchester University, UK
Parkinson's as a metabolism disorder
› Glending III
12:00 - 12:15 (15min)
Proteomic advancements in neurodegenerative disorders
Glending III
Dhruti Doddaballapur, Manchester University, UK
Parkinson's as a metabolism disorder
›12:15 (15min)
Proteomic advancements in neurodegenerative disorders
William Ryan, University of Toledo, USA
Differences between cell type specific protein kinase expression and functional activity in cerebral cortex.
William Ryan, University of Toledo, USA
Differences between cell type specific protein kinase expression and functional activity in cerebral cortex.
› Glending III
12:15 - 12:30 (15min)
Proteomic advancements in neurodegenerative disorders
Glending III
William Ryan, University of Toledo, USA
Differences between cell type specific protein kinase expression and functional activity in cerebral cortex.
12:30 - 13:30 (1h)
Lunch
VI's
›13:30 (1h)
Proteomic applications and developments in academic-Industry collaborations
Keynote
Christopher Whelan, Janssen Research & Development, LLC
Population-scale proteomics provides insights into diagnostics & therapeutics for human disease
Keynote
Christopher Whelan, Janssen Research & Development, LLC
Population-scale proteomics provides insights into diagnostics & therapeutics for human disease
› Glending III
13:30 - 14:30 (1h)
Proteomic applications and developments in academic-Industry collaborations
Glending III
Keynote
Christopher Whelan, Janssen Research & Development, LLC
Population-scale proteomics provides insights into diagnostics & therapeutics for human disease
›14:30 (15min)
Proteomic applications and developments in academic-Industry collaborations
Karin Yeoh, Preomics, Munich, Germany
Title…TBC
Karin Yeoh, Preomics, Munich, Germany
Title…TBC
› Glending III
14:30 - 14:45 (15min)
Proteomic applications and developments in academic-Industry collaborations
Glending III
Karin Yeoh, Preomics, Munich, Germany
Title…TBC
›14:45 (15min)
Proteomic applications and developments in academic-Industry collaborations
Melanie Föcking, RCSI University of Medicine and Health Sciences
Our journey to greater Sustainability, My Green Lab Accreditation
Melanie Föcking, RCSI University of Medicine and Health Sciences
Our journey to greater Sustainability, My Green Lab Accreditation
› Glending III
14:45 - 15:00 (15min)
Proteomic applications and developments in academic-Industry collaborations
Glending III
Melanie Föcking, RCSI University of Medicine and Health Sciences
Our journey to greater Sustainability, My Green Lab Accreditation
15:00 - 19:00 (4h)
Networking / free time with possibility to visit National Stud and Japanese Garden Kildare
19:00 - 22:00 (3h)
Dinner (BBQ)
Ball Room / Outdoor
